-
for 36 h. NaHCO3 was filtered off. The dark brown solution
was evaporated. The remaining oily solid was extracted with
chloroform (3 ¥ 5 mL). The remaining solid (0.039 g, 81%)
was used without further purification. 1H-NMR (400 MHz,
MeOD/CD3CN 1 : 1, 233 K) (13C 100 MHz): d = 1.7 (32.5) (s br, 2
H; CH2), 2.2 (109.7) (s br, 2 H; Ar), 2,5 (30.8) (s br, 2 H; CH2), 2.7
(67.4) (s br, 2 H; ethyleneoxy), 3.3 (51, 64) (s, 8 H; OCH2, OMe),
3.4 (32.5) (s, 6 H; NMe), 3.5–3.8 (m br, 16 H; ethyleneoxy), 3.7 (74)
(s br, 2 H; ethyleneoxy), 4.2 (67.4) (s br, 2 H; OCH2), 4.4 (127.8) (s
br, 2 H; Ar), 4.5 (48.7) (m, br, 2 H; NCH2), 5.6–5.7 (64.1) (m br, 8
H; CBQT4+), 6.7 (113.7) (d, J = 9 Hz, 2 H; aryl), 6.8 (120) (m, br, 4
H; acridane, H-2,7), 7.03 (d, J = 9 Hz, 2 H; aryl), 7.2–7.6 (m br, 20
H; acridane, CBQT4+), 8.1 (127) (s br, 4 H; CBQT4+), 8.3 (127) (s
br, 4 H; CBQT4+), 8.6 (144.3) (s br, 4 H; CBQT4+), 8.9 (145.1) (s br,
4 H; CBQT4+); HRMS (ESI): m/z: found 952.8625 calcd. for (M –
for [M – 3PF6 ] [C92H93F18N11O5P3]3+: 622.2090;); found: 430.4160
-
calcd for [M – 4PF6 ] [C92H93F12N11O5P2]4+: 430.4156.
The dichloromethane solution containing the free axle was
evaporated. The remaining residue was purified by column
chromatography (NH4PF6 (7 g) in MeCN (400 mL)/ethylacetate
(200 mL)/cyclohexane (100 mL) to give pure 20 (0.15 g, 19%)
as an orange, resinous compound. 1H NMR (400 MHz, CD3CN,
TMS) (13C 100 MHz): d = 3.1 (38.6) (s, 3 H; NMe), 3.36 (43.2) (t,
J(H,H) = 5.5 Hz, 2 H; NH–CH2), 3.5–3.7 (68.4, 69.1, 69.3, 69.6,
70.2, 70.3, 70.4) (m, 16 H; ethyleneoxy), 3.85 (t, J(H,H) = 5.3 Hz, 2
H; OCH2), 4.47 (50.1) (t, J(H,H) = 5.0 Hz, 2 H; NCH2), 4.58 (63.9)
(s, 2 H; OCH2), 4.71, 4.72 (38.8) (ds, 6 H; N+Me), 6.92 (112.2) (d,
J(H,H) = 8.5 Hz, 2 H; Ar), 7.02 (111.7) (d, J(H,H) = 8.8 Hz, 2
H; Ar), 7.29 (132.8) (d, J(H,H) = 8.7 Hz, 2 H; Ar), 7.36 (132.8)
(d, J(H,H) = 9.0 Hz, 2 H; Ar), 7.8 (127.2) (m, 4H; acridinium,
H-2,7), 8.21 (130.9) (d, J(H,H) = 8.7 Hz, 2 H; acridinium, H-1,8),
8.28 (m, 2 H; acridinium, H-3,6), 8.49 (d, J(H,H) = 9.3 Hz, 2 H;
acridinium, H-4,5); HRMS (ESI): m/z: found 1056.4355; calcd for
2PF6 ), [C102H105F12N9O10P2]2+: 952.8629; found 586.9198; calcd.
-
for (M – 3PF6 ), [C102H105F6N9O10P]3+: 586.9203; found 403.9497
-
calcd. for (M – 4PF6 ), [C93H95N9O9]4+): 403.9491.
-
-
[M – PF6 ] [C56H61F6O5N7P]+: 1056.4371;]; found 455.7365; calcd
for [M – 2PF6 ] [C56H61O5N7]2+: 455.7362.
-
Rotaxane 19
A solution of 17 (ESI†) (0.35 g, 0.72 mmol), 18 (ESI†) (0.44 g,
0.72 mmol) and CBQT(PF6)4 (0.79 g, 0.72 mmol) in dry DMF
(2 mL) was stirred for 30 min under an argon atmosphere.
A solution of CuSO4¥5H2O (0.10 g, 0.37 mmol) and sodium
ascorbate (0.14 g, 0.72 mmol) in water (0.8 mL) was added
within 15 min. The resulting suspension was stirred at room
temperature for 2 days. The reaction mixture was evaporated
Rotaxane 21
NaHCO3 (0.2 g) was added to the acridinium rotaxane 19 (0.150 g,
0.065 mmol) dissolved in acetonitrile (5 mL) under addition
of methanol (0.1 mL). The suspension was stirred for 36 h.
NaHCO3 was filtered off. The dark blue solution was evaporated.
The remaining oily solid was extracted with chloroform (3 ¥
5 mL). The remaining solid (0.130 g, 96%) was used without
further purification. UV-Vis (lmax/nm (e/M-1cm-1): 265 (68900);
1H-NMR (400 MHz, MeOD/CD3CN 2 : 1) (13C 100 MHz): d =
1.9 (108.2) (s br, 2 H; Ar), 2.0 (43.9) (s br, 2 H; NCH2), 2.7 (38.2)
(s, 3 H; NMe), 3.2 (48.8) (s, 3 H; OMe), 3.3 (52.3) (s, 3 H; OMe),
3.6–3.8 (32.5, 70.0) (m, 24 H; NMe, ethyleneoxy), 4.1 (63.0) (s,
2 H; OCH2), 4.3 (49.9) (t, J(H,H) = 5.1 Hz, 2 H; NCH2), 4.4
(49.9) (m, 2 H; NCH2), 4.45 (128.5) (s, br, 2 H; Ar), 5.7 (63.7) (s
br, 8 H; CBQT4+), 6.5 (111) (s br, 2 H, Ar), 6.8 (120.0) (s br, 4 H;
acridane, H-2,7), 7.1–7.4 (113, 128.7, 128.9) (m br, 12 H; acridane)
7.6 (127, 130) (s br 16 H; CBQT4+), 8.7 (s br, 8 H; CBQT4+).
◦
in vacuo at 90 C. The resulting residue was treated with MeCN
(10 mL) and NH4PF6 (5% in MeCN). The precipitate was
filtered and the filtrate was evaporated. The resulting oil was
extracted with dichloromethane in order to dissolve compound
20. The insoluble residue was treated with 8 mL of a solution
of NH4PF6 (7 g) in MeCN (400 mL), ethyl acetate (200 mL),
and cyclohexane (100 mL). Free CBQT(PF6)4 was filtered off.
The solution was chromatographed (NH4PF6 (7 g) in MeCN
(400 mL)/ethylacetate (200 mL)/cyclohexane (100 mL). The
violet fractions were collected and the solvents were removed.
The resulting dark violet solid was washed with water and dried in
vacuum to give 19 (0.295 g, 18%), m.p. 185 ◦C. UV-Vis (lmax/nm
(e/M-1cm-1): 257.5 (180700), 343.5 (14400), 358.5 (27000), 412
HRMS (ESI): m/z: found 948.8233; calcd. for (M - MeO-
-
PF6 ), [C93H96F18N11O6P3]2+: 948.8235; found 891.8501; calcd for
-
[M–2 PF6 ], [C94H99F12N11O7P2]2: 891.8501; found 584.2276; calcd
-
1
(6000), 530 (16400); H NMR (400 MHz, CD3CN, TMS) (13C,
for [M - MeO- - 2PF6 ], [C93H96F12N11O6P2]3+:584.2276; found
-
100 MHz): d = 1.24 (43.3) (s, br, 2 H; NHCH2), 3.03 (38.9) (s,
br, 3 H; NMe), 3.5 (67.8) (m, 2 H; OCH2), 3.5 (69.5) (m, 2 H;
ethyleneoxy), 3.6 (51.8) (m, 2 H; NMeCH2), 3.6–3.8 (70.3, 70.5)
(m, 16 H; ethyleneoxy), 4.08 (109.3) (d, J = 9 Hz, 2 H; aryl), 4.21
(49.7) (t, J = 5 Hz, 2 H; NCH2), 4.73 (38.6) (s, 3 H; N+Me), 4.82
(38.6) (s, 3 H; N+Me), 5.73 (64.9) (m, 8 H; CBQT4+), 6.57(124.1)
(s, 1 H; triazole), 6.67 (133.2) (d, J = 9 Hz, 2 H; aryl), 6.97 (111.4)
(d, J = 8 Hz, 2 H; aryl), 7.37 (133.2) (d, J = 8 Hz, 4 H; aryl), 7.73
(131.1) (s, 8 H; CBQT4+), 7.80 (127.9) (m, 2 H, acridinium, H-2,7),
7.85 (130.4) (d, J = 9 Hz, 2 H; acridinium, H-1,8), 8.07 (127.3) (d,
J = 7 Hz, 8 H; CBQT4+); 8.1 (127.9) (m, 2 H; acridinium, H-2,7),
8.20 (130.4) (d, J = 9 Hz, 2 H; acridinium, H-1,8), 8.31 (138.8) (m,
2 H; acridinium, H-3,6), 8.44 (138.8) (m, 2 H; acridinium, H-3,6),
8.51 (118.7) (d, J = 9 Hz, 2 H; acridinium, H-4,5), 8.62 (118.9) (d,
J = 9 Hz, 2 H; acridinium, H-4,5), 8.94 (145.5) (d, J = 7 Hz, 8 H;
CBQT4+); HRMS (ESI): m/z: found: 1005.7961; calcd for [M –
546.2464; calcd for [M – 3PF6 ], [C94H99F6N11O7P]3+: 546.2451;
-
found 401.9294 calcd for [M - MeO- - 3PF6 ] [C93H96F6N11O6P]4+:
-
401.9297.
Notes and references
1 (a) J. F. Stoddart, Acc. Chem. Res., 2001, 34, 410–411; (b) C. A. Schalley,
K. Beizai and F. Vo¨gtle, Acc. Chem. Res., 2001, 34, 465–476; (c) V.
Balzani, M. Venturi and A. Credi, Molecular Devices and Machines,
Wiley-VCH, Weinheim 2003; (d) E. R. Kay, D. A. Leigh and F. Zerbetto,
Angew. Chem., 2007, 119, 72–196;Angew. Chem., Int. Ed., 2007, 46, 72–
191; (e) S. Saha and J. F. Stoddart, Chem. Soc. Rev., 2007, 36, 77–92.
2 M. C. T. Fyfe, P. T. Glink, S. Menzer, J. F. Stoddart, A. J. P. White and
D. J. Williams, Angew. Chem., 1997, 109, 2158–2160; Angew. Chem.,
Int. Ed. Engl., 1997, 36, 2068–2070.
3 W. Clegg, C. Gimenez-Saiz, D. A. Leigh, A. Murphy, A. M. Z. Slawin
and S. J. Teat, J. Am. Chem. Soc., 1999, 121, 4124–4129.
4 R. A. Bissel, E. Cordova, A. E. Kaifer and J. F. Stoddart, Nature, 1994,
369, 133–137.
-
2PF6 ] [C92H93F24N11O5P4]2+: 1005.7959; found: 622.2094; calcd
4680 | Org. Biomol. Chem., 2010, 8, 4666–4681
This journal is
The Royal Society of Chemistry 2010
©